Kevin Lin

Dec 5, 2024 | bit.kevinslin.com | Kevin Lin

On a rainy March day in 1538, Thomas Howard, the Duke of Norfolk, found himself confined within the cold stone walls of his grand estate. His fingers reluctantly penned a letter to sell his cherished lands to settle longstanding debts. "A man can not have his cake and eat his cake", he wrote, the words etched with the pain of having to confront a reality that he did not want to accept. This was the earliest written record of the proverb "you can't have your cake and eat it too".

Nov 26, 2024 | medium.com | Kevin Lin

Using the BUIDL Fund as a case study to explore its structure andl mechanisms, while analyzing the long-term growth prospects of the RWA market. Kevin Lin·FollowPublished inBSOS Taiwan·10 min read·--The Tokenization of U.S. Treasuries Ignites the Growth of RWAThe advancement of blockchain technology has been a significant driver behind the expanding influence of the asset tokenization market.

Oct 25, 2024 | jamanetwork.com | Kevin Lin |Thomas C. Tsai

Introduction Use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) semaglutide and liraglutide as antiobesity medications has surged in recent years.1,2 Anecdotally, health systems have closed hospital-based metabolic bariatric surgery programs due to decreased demand, but empirical data on the association of increased prescribing of GLP-1 RAs with use of metabolic bariatric surgery is unavailable, to our knowledge.

Aug 31, 2024 | kevinlinxc.medium.com | Kevin Lin

While playing piano recently, I’ve reflected on how various aspects of practicing music are also great metaphors for life. In many ways, the struggles of learning a new piece are a microcosm of the struggles of life. By the end of this article, I hope you’ll have learned something new, or at least a new way to express something you’ve already long known.

Aug 16, 2024 | jamanetwork.com | Lori Uscher-Pines |Kevin Lin

Alcohol use disorder (AUD) is the most common substance use disorder in the US, affecting 11% of adults.1 Efficacious medications to treat AUD, such as naltrexone and acamprosate, exist but are seldom prescribed; in fact, only 2.1% of adults with AUD receive medication treatment in a given year.1 Key barriers to prescribing AUD medications in primary care include lack of physician knowledge, concerns about efficacy, and treatment philosophy and stigma.2 Many clinicians are uncomfortable...